Histoplasmosis in Dogs: Symptoms, Diagnosis, Treatment, and Geographic Guide
This article is reviewed for clinical accuracy. Always consult your veterinarian for diagnosis and treatment.
Key Takeaways
- Histoplasmosis in dogs is caused by Histoplasma capsulatum var. capsulatum, a thermally dimorphic fungus with the same two-form life cycle as Blastomyces: a mold form (mycelium with microconidia and macroconidia) in the soil at ambient temperatures, and a small yeast form (2 to 4 micrometers in diameter) in host tissue at body temperature; the yeast form is critically important to understand because it is obligately intracellular, meaning H. capsulatum survives and replicates inside macrophages and other mononuclear phagocytes rather than in extracellular tissue fluids; this intracellular strategy allows the organism to evade many humoral and complement-mediated immune defenses and to disseminate through the body within the very phagocytes tasked with destroying it, following macrophage traffic routes to the gastrointestinal tract, liver, spleen, bone marrow, adrenal glands, and lymph nodes.
- The environmental niche for H. capsulatum is distinct from but overlapping with Blastomyces: both fungi are endemic to the Mississippi and Ohio River valleys, but Histoplasma is specifically enriched in soil contaminated with bird droppings (particularly European starlings, red-winged blackbirds, grackles, and domestic chickens) and bat guano; areas at highest risk include old chicken coops (where accumulated droppings have composted over years), active and historical starling and blackbird roost sites (often in urban areas around bridges, buildings, and tree groves where enormous flocks roost overnight), cave systems and mine shafts inhabited by bats, and river bottom soils where roosting birds congregate; soil disturbance at these sites (demolition of old chicken houses, excavation near roost sites, spelunking in bat caves) creates explosive aerosol release of conidia and is responsible for point-source outbreak clusters in dogs and humans.
- Unlike blastomycosis (which is predominantly a respiratory disease in dogs), histoplasmosis in dogs most commonly presents as a gastrointestinal disease with chronic diarrhea, severe weight loss, and protein-losing enteropathy; this GI-dominant presentation occurs because macrophages carrying H. capsulatum yeast traffic from the lung through lymphatics and blood to the lamina propria and Peyer’s patches of the small intestine, where macrophage density is high; the resulting granulomatous infiltration of the intestinal wall causes malabsorption (villous blunting, reduced absorptive surface area), protein-losing enteropathy (hypoalbuminemia from GI protein loss), and large bowel disease (thickened, ulcerated colon producing mucoid hematochezia and tenesmus); the combination of profound hypoalbuminemia, ascites, and chronic diarrhea in a dog from an endemic area is a classic presentation that should immediately prompt consideration of histoplasmosis.
- The most clinically important diagnostic shortcut for canine histoplasmosis is the rectal mucosal scraping cytology: because GI dissemination delivers Histoplasma-laden macrophages to the rectal mucosa, a simple scraping of the rectal mucosa with a blunt curette or tongue depressor, smearing the material on a glass slide, and staining with Diff-Quik or Wright-Giemsa will reveal intracellular yeast within macrophages in many dogs with active GI histoplasmosis; this procedure requires no anesthesia, costs far less than endoscopy and biopsy, and can provide a same-day diagnosis in a clinically ill dog; fine-needle aspiration of enlarged peripheral lymph nodes, liver, or spleen also frequently reveals the organism; the urine Histoplasma antigen EIA (MiraVista Diagnostics) is the most sensitive non-invasive test, with approximately 85 to 90 percent sensitivity in dogs with active disseminated infection.
- The treatment of choice for canine histoplasmosis is itraconazole at 5 mg/kg orally once daily with a fatty meal; the minimum treatment duration for mild to moderate GI or disseminated disease is 4 to 6 months (considerably longer than for blastomycosis), reflecting the intracellular location of H. capsulatum, which makes complete eradication more difficult; severely hypoalbuminemic dogs require concurrent supportive therapy including high-protein, highly digestible diets, and sometimes colloidal support or plasma transfusions to manage protein-losing enteropathy during the early treatment period; urine antigen concentrations decline with successful treatment and provide an objective endpoint for therapy; treatment should continue for at least 30 days past antigen negativity, not just past clinical resolution.
- The prognosis for dogs with histoplasmosis depends heavily on disease severity at presentation: dogs with mild to moderate GI disease and adequate serum albumin (above 2.0 g/dL) that are started on itraconazole promptly generally have a good to excellent prognosis with survival rates above 70 to 80 percent in most reports; dogs with severe hypoalbuminemia (below 1.5 g/dL) secondary to massive protein-losing enteropathy, pancytopenia from bone marrow infiltration, or confirmed adrenal involvement carry a guarded to poor prognosis; dogs with histoplasmic meningitis or ocular involvement (chorioretinitis, uveitis) require CNS-penetrant antifungals (fluconazole preferred over itraconazole for CNS disease) and have unpredictable outcomes.
The 5-year-old Border Collie had been treated for “inflammatory bowel disease” for six weeks before the referral arrived. Three veterinarians had seen her: the first prescribed a hydrolyzed protein diet and metronidazole for chronic small bowel diarrhea and weight loss; the second added prednisolone when the diarrhea persisted; the third stopped the steroids when the dog deteriorated further on immunosuppression. On presentation at the internal medicine service, the dog had lost 4.2 kg over eight weeks, was profoundly lethargic, and had a serum albumin of 1.3 g/dL with moderate ascites. Abdominal ultrasound showed diffuse hepatomegaly, marked splenomegaly, and thickened intestinal walls. The owner mentioned, almost as an afterthought, that the dog had spent every summer at a farm in southwestern Missouri near a creek bottom with a large starling roost. A rectal mucosal scraping was performed the same afternoon. The smear showed dozens of macrophages packed with small intracellular yeast organisms: Histoplasma capsulatum. Itraconazole was started that evening, prednisolone was not restarted, and a high-protein digestible diet replaced the hydrolyzed formula. At the 6-week recheck the albumin had risen to 2.2 g/dL and the diarrhea had resolved.
The Organism: Intracellular Dimorphic Fungus
Histoplasma capsulatum is a thermally dimorphic fungus with two distinct morphological forms determined by temperature:
| Feature | Environmental (Mold) Form | Tissue (Yeast) Form |
|---|---|---|
| Temperature | Below 35 degrees Celsius (soil, decaying matter) | 37 degrees Celsius (mammalian body temperature) |
| Morphology | Septate hyphae bearing large tuberculate macroconidia (8 to 14 micrometers, thick-walled with fingerlike projections) and small smooth microconidia (2 to 5 micrometers); microconidia are the primary infectious particles due to their small size | Small oval yeast cells (2 to 4 micrometers); very small compared to Blastomyces (8 to 15 micrometers); narrow-based budding (not broad-based as in Blastomyces) |
| Cell behavior | Free-living saprophyte in bird/bat-enriched soil | Obligately intracellular: survives and replicates within macrophage phagolysosomes; inhibits phagosome-lysosome fusion; disseminates via infected macrophage trafficking |
| Identification on cytology | Not seen in clinical specimens (diagnostic relevance is environmental sampling only) | Small oval basophilic yeast within macrophage cytoplasm; often seen as clusters of 2 to 20 organisms in a single macrophage; narrow halo artifact around each yeast on Diff-Quik (gives the appearance of a capsule, though H. capsulatum does not have a true polysaccharide capsule) |
Histoplasmosis vs. Blastomycosis: Key Clinical Differences
| Feature | Histoplasmosis | Blastomycosis |
|---|---|---|
| Causative organism | Histoplasma capsulatum (2 to 4 micrometer yeast, intracellular) | Blastomyces dermatitidis (8 to 15 micrometer yeast, extracellular, broad-based budding) |
| Primary target organ in dogs | Gastrointestinal tract (macrophage trafficking); liver, spleen, bone marrow | Lungs (pulmonary pyogranulomatous pneumonia) |
| Dominant clinical signs | Chronic diarrhea, weight loss, hypoalbuminemia, hepatosplenomegaly, peripheral lymphadenopathy | Cough, exercise intolerance, miliary nodular lung pattern on radiographs |
| Fastest clinical diagnosis | Rectal mucosal scraping cytology (no anesthesia required) | Fine-needle aspirate of skin lesion or lymph node |
| Urine antigen test | MiraVista Histoplasma antigen EIA (approximately 85 to 90 percent sensitivity) | MiraVista Blastomyces antigen EIA (approximately 90 percent sensitivity) |
| Radiographic pulmonary pattern | Diffuse interstitial infiltrate or nodular pattern; less commonly mistaken for cancer than blastomycosis | Diffuse miliary nodular interstitial pattern frequently mistaken for pulmonary metastatic cancer |
| Treatment duration | 4 to 6 months minimum; often longer | 2 to 3 months minimum |
| Environmental source | Bird/bat guano-enriched soil, old chicken coops, roost sites, caves | Moist sandy/loamy soil near rivers, lakes, beaver ponds |
Geographic Distribution and Risk Factors
| Region | States/Areas | Key Environmental Feature |
|---|---|---|
| Mississippi and Ohio River valleys (core endemic zone) | Missouri, Arkansas, Tennessee, Mississippi, Kentucky, Indiana, Illinois, Iowa, Ohio | River bottom soils with dense bird roost concentrations; starling and blackbird migratory corridors |
| Mid-Atlantic and Appalachian region | Pennsylvania, Maryland, Virginia, West Virginia, North Carolina | Cave systems with bat populations; old farm buildings with chicken/poultry history |
| Great Lakes peripheral zone | Michigan, Wisconsin (less prevalent than blastomycosis here), Minnesota | Overlap with blastomycosis endemic zone; river corridors with bird roost sites |
| Central America/Caribbean (travel history) | Mexico, Central America; imported cases in US | Large bat cave populations; widespread soil contamination in tropical areas |
Within endemic areas, specific exposures create elevated risk:
- Old chicken coops and poultry houses: decades of accumulated droppings create a rich substrate for Histoplasma growth; demolition or renovation of old farm structures is a classic exposure scenario; dogs that den under or dig in areas of old poultry operations are at high risk
- Active starling and blackbird roost sites: winter roost aggregations of hundreds of thousands of birds in urban areas (under bridges, in shopping center parking lot trees, in industrial areas) deposit enormous quantities of droppings; dogs exercised near these sites breathe in contaminated dust
- Bat caves (spelunking environments): humans who bring dogs into bat-inhabited caves face significant exposure risk; guano deposits on cave floors support dense Histoplasma growth; disturbance of cave floor dust releases conidia
- Construction and excavation near endemic sites: soil disturbance near historical chicken operation sites or bird roost areas aerosolizes conidia; dogs in rural areas undergoing farm renovation or construction near old outbuildings face point-source exposure risk
- Dogs that dig extensively: earth-digging behavior concentrates oral/nasal exposure to potentially contaminated soil; terrier breeds and other breeds with strong digging behavior in endemic areas face elevated exposure risk
Clinical Signs by System
| System | Clinical Signs | Frequency |
|---|---|---|
| Gastrointestinal (primary in dogs) | Chronic small bowel diarrhea (voluminous, watery, non-bloody or mildly bloody); large bowel diarrhea (mucoid, hematochezia, tenesmus, increased urgency); weight loss; decreased appetite; vomiting; malabsorption | Present in 60 to 80 percent of dogs with histoplasmosis; the most common presenting complaint |
| Protein-Losing Enteropathy | Hypoalbuminemia (serum albumin below 2.0 g/dL); pitting edema of the distal limbs; ascites; pleural effusion; peripheral edema; muscle wasting | Common in dogs with significant GI dissemination; severe hypoalbuminemia (below 1.5 g/dL) indicates advanced GI wall infiltration |
| Hepatic/Splenic | Hepatomegaly; splenomegaly; elevated liver enzymes (ALT, ALP, GGT); hyperbilirubinemia in severe hepatic involvement; abdominal distension | Common; liver and spleen are major sites of macrophage-mediated dissemination |
| Lymphatic | Generalized peripheral lymphadenopathy; mesenteric lymph node enlargement; intrathoracic hilar adenopathy | Common; lymph nodes are frequently positive on fine-needle aspirate cytology |
| Bone Marrow/Hematologic | Non-regenerative anemia; thrombocytopenia; leukopenia; pancytopenia; hyperglobulinemia | Moderate prevalence; bone marrow aspirate cytology shows intracellular yeast within macrophages in positive cases |
| Respiratory | Cough; increased respiratory effort; exercise intolerance; diffuse interstitial pattern on thoracic radiographs; hilar lymphadenopathy | Less prominent than in blastomycosis; pulmonary signs may be subclinical while GI disease dominates the presentation |
| Adrenal | Signs of hypoadrenocorticism (Addison’s-like syndrome: weakness, hypotension, hyperkalemia, hyponatremia); adrenal glands enlarged bilaterally on ultrasound | Uncommon but documented; adrenal gland granulomatous infiltration can destroy adrenocortical tissue; always evaluate electrolytes in dogs with suspected histoplasmosis |
| Ocular/CNS | Chorioretinitis; uveitis; optic neuritis; meningitis; seizures; ataxia | Uncommon; CNS histoplasmosis carries the worst prognosis; ocular signs may precede other signs |
Diagnosis
Rectal Mucosal Scraping Cytology
The rectal mucosal scraping is the most practical same-day diagnostic test for canine histoplasmosis and requires no anesthesia or sedation; the procedure involves gently inserting a blunt curette or the edge of a tongue depressor approximately 2 to 4 cm into the rectum and scraping the mucosal surface to collect a small amount of mucosal material; the material is smeared on a glass slide, air-dried, and stained with Diff-Quik or Wright-Giemsa; in positive cases, macrophages loaded with small intracellular yeast organisms (appearing as clusters of small oval basophilic structures within macrophage cytoplasm) are visible at 40x to 100x magnification; the sensitivity of rectal scraping cytology for histoplasmosis is approximately 50 to 70 percent in dogs with confirmed disease, meaning a negative result does not rule out the diagnosis, but a positive result is nearly pathognomonic in the appropriate clinical context.
Urine Histoplasma Antigen EIA (MiraVista)
The MiraVista Histoplasma urinary antigen enzyme immunoassay is the most sensitive non-invasive diagnostic test, with approximately 85 to 90 percent sensitivity in dogs with active disseminated histoplasmosis; the assay detects Histoplasma galactomannan antigen shed by actively replicating yeast and excreted in urine; important clinical notes about this test: cross-reactivity with Blastomyces antigen occurs (a dog with blastomycosis may have a positive Histoplasma antigen test and vice versa), making species-specific diagnosis dependent on cytology or culture when antigen results are ambiguous; serum antigen testing is less sensitive than urine antigen in dogs; serial urine antigen monitoring at 30-day intervals during treatment tracks treatment response; antigen levels should decline progressively with successful itraconazole therapy, and persistent elevation or rising values during treatment suggest treatment failure or inadequate drug levels.
Fine-Needle Aspirate Cytology
Enlarged peripheral lymph nodes (submandibular, prescapular, popliteal, axillary), spleen, and liver are readily accessible for fine-needle aspiration without anesthesia in most dogs; aspiration of these organs frequently yields macrophages containing Histoplasma yeast in dogs with systemic dissemination; cytological confirmation of small intracellular yeast organisms in macrophages is diagnostic; the differential for small intracellular organisms includes Leishmania (which is morphologically similar but geographically distinct in the US; relevant for dogs with travel history to endemic areas in southern Europe, South America, or the Middle East), Toxoplasma (intracellular tachyzoites, different morphology), and Cytauxzoon felis (cats only); in the clinical context of a dog from the US Mississippi Valley with GI signs and the cytological finding of small intracellular oval organisms in macrophages, histoplasmosis is overwhelmingly the most likely diagnosis.
Gastrointestinal Endoscopy and Biopsy
Colonoscopy and colonoscopic biopsy (particularly of the ileocolic junction and colon) frequently demonstrate diffuse granulomatous mucosal infiltration with macrophages containing Histoplasma yeast on histopathology; the colonic mucosa appears thickened, irregular, and ulcerated on endoscopy; PAS (periodic acid-Schiff) stain and GMS (Grocott methenamine silver) stain on histological sections highlight the yeast organisms when routine H&E staining is ambiguous; endoscopy is more invasive and expensive than a rectal scraping but provides both a diagnostic specimen and direct visualization of the mucosal lesion severity.
Thoracic Radiography and Abdominal Ultrasound
Thoracic radiographs in dogs with histoplasmosis may show a diffuse interstitial or nodular infiltrate and hilar lymphadenopathy, but pulmonary changes are often mild or absent in dogs presenting primarily with GI disease; abdominal ultrasound consistently shows hepatomegaly, splenomegaly, mesenteric lymphadenopathy, and diffuse intestinal wall thickening; ascites is visible as free fluid; the combination of these ultrasound findings in a dog from an endemic area with chronic diarrhea and hypoalbuminemia should place histoplasmosis high on the differential diagnosis before any other workup.
Treatment
Itraconazole (Standard First-Line Therapy)
Itraconazole at 5 mg/kg orally once daily (or divided twice daily) with a fatty meal is the treatment of choice for canine histoplasmosis, following the same protocol as for blastomycosis but with a longer treatment duration; minimum treatment duration is 4 to 6 months for mild to moderate disease; dogs with severe disseminated disease, bone marrow involvement, or adrenal histoplasmosis may require 6 to 12 months of treatment; the same bioavailability concerns apply as for blastomycosis treatment: Sporanox brand capsules have better-documented bioavailability in dogs than generic itraconazole or most compounded formulations; monthly liver enzyme monitoring (ALT, ALP) is required throughout the treatment course; the same adverse effect profile applies: hepatotoxicity in approximately 5 to 10 percent of dogs and cutaneous vasculitis producing limb edema.
Fluconazole (CNS Disease or Itraconazole Intolerance)
Fluconazole at 2.5 to 5 mg/kg orally twice daily is an alternative for dogs that cannot tolerate itraconazole or for dogs with CNS histoplasmosis; fluconazole’s superior CNS penetration (CSF concentrations approximately 70 to 80 percent of plasma) makes it the preferred agent when meningitis, encephalitis, or optic neuritis is present; fluconazole does not require food for absorption and has no significant food interaction; it is less active against Histoplasma in vitro compared to itraconazole, but clinical outcomes for non-CNS disease are generally comparable.
Amphotericin B (Severe Disease)
Amphotericin B (conventional deoxycholate or lipid formulations) is reserved for dogs with severe, rapidly progressive histoplasmosis, respiratory compromise, or CNS disease requiring urgent fungicidal activity; it is given by slow IV infusion with careful renal function monitoring; lipid-formulation products (AmBisome, Abelcet) have significantly lower nephrotoxicity and are preferred when available; AMB is typically used as induction therapy followed by oral itraconazole for long-term consolidation once the dog is stabilized.
Supportive Care for Protein-Losing Enteropathy
Dogs with severe hypoalbuminemia require nutritional and supportive management concurrent with antifungal therapy:
- Diet: highly digestible, high-protein diet (not hydrolyzed protein; hydrolyzed protein diets are appropriate for immune-mediated IBD but are typically lower in protein content and may worsen the negative nitrogen balance in histoplasmosis-associated PLE); a fresh food or cooked diet with high-quality animal protein is often better tolerated and nutritionally more appropriate than ultra-processed therapeutic diets during recovery
- Albumin support: fresh frozen plasma or human serum albumin infusions may be needed in dogs with serum albumin below 1.5 g/dL and clinical signs of third-space fluid accumulation (ascites, pleural effusion, limb edema)
- Avoid immunosuppression: corticosteroids and other immunosuppressants must not be used in dogs with active histoplasmosis; immunosuppression allows the intracellular organism to replicate unchecked within macrophages and dramatically worsens the disease; the most dangerous diagnostic error is treating histoplasmosis as immune-mediated IBD and prescribing prednisolone
- Antiparasitic coverage: intestinal parasites (including Giardia) worsen protein-losing diarrhea and should be tested for and treated concurrently
US Cost Overview for Histoplasmosis
| Service | Typical US Cost |
|---|---|
| Veterinary examination | $60 to $150 |
| Complete blood count and chemistry panel (including albumin) | $150 to $300 |
| Rectal mucosal scraping cytology (in-house) | $30 to $80 |
| Fine-needle aspirate with cytology | $100 to $250 |
| Urine Histoplasma antigen EIA (MiraVista) | $60 to $100 |
| Thoracic radiographs (two views) | $150 to $350 |
| Abdominal ultrasound | $250 to $600 |
| Colonoscopy with biopsy and histopathology | $600 to $1,500 |
| Bone marrow aspirate and cytology | $300 to $700 |
| Itraconazole (Sporanox, 6-month course, 20 kg dog) | $300 to $700 |
| Fluconazole (6-month course, 20 kg dog) | $80 to $240 |
| Monthly liver enzyme monitoring | $80 to $150 per recheck |
| Urine antigen monitoring (monthly) | $60 to $100 per test |
| Fresh frozen plasma or albumin infusion | $200 to $600 per unit |
Age-Specific Considerations
Puppies (Under 12 Months)
- Young dogs have an incompletely mature cell-mediated immune response, which is the primary defense mechanism against intracellular pathogens like Histoplasma; the CD4+ T-helper 1 (Th1) response that activates macrophages to kill intracellular yeast is less robust in puppies, potentially allowing more rapid intramacrophage replication and wider dissemination; a puppy from an endemic area with chronic diarrhea, failure to thrive, and low serum albumin should have histoplasmosis on the differential from the first visit, before any diagnosis of “puppy inflammatory bowel disease” is considered
- Protein-losing enteropathy in a puppy is a medical emergency: because puppies have lower total protein stores and albumin synthesis capacity than adults, the hypoalbuminemia associated with histoplasmosis PLE can reach critically low levels (below 1.0 g/dL) faster in puppies; third-space fluid accumulation causing ascites and pleural effusion in a puppy warrants immediate evaluation including rectal scraping cytology and urine antigen testing
- Itraconazole dosing in puppies follows the same weight-based protocol as adult dogs; monthly liver enzyme monitoring is particularly important in rapidly growing puppies because hepatic drug metabolism rates change with growth; if hepatotoxicity develops, fluconazole is the preferred alternative; the 4 to 6-month treatment course represents a significant portion of a puppy’s first year of life, so compliance and monitoring support from the owner are important for treatment success
Adult Dogs (1 to 8 Years)
- Adult dogs represent the majority of histoplasmosis cases in published veterinary series; the most dangerous diagnostic pattern in adult dogs is the misdiagnosis of histoplasmosis as immune-mediated inflammatory bowel disease, which leads to corticosteroid therapy; in any adult dog from an endemic area presenting with chronic diarrhea, weight loss, and hypoalbuminemia, histoplasmosis must be excluded by urine antigen testing and cytology before immunosuppressive therapy is initiated; administering corticosteroids to a dog with active histoplasmosis can cause rapid clinical deterioration through uncontrolled intracellular fungal replication
- Adult working dogs, farm dogs, and dogs in rural environments near bird roost sites or old agricultural buildings in the Mississippi/Ohio River valley states are at highest baseline risk; owners of dogs in these environments should know the characteristic signs of histoplasmosis (chronic diarrhea, weight loss, lethargy, swollen lymph nodes) and should mention any recent exposure to old chicken coops, demolition activity near farm structures, or caves when presenting to their veterinarian
- The treatment duration (4 to 6 months) requires owner commitment; many adult dogs feel significantly better within the first 4 to 6 weeks of itraconazole therapy, and owners may be tempted to stop medication when clinical signs resolve; stopping itraconazole early is a major cause of relapse; the urine antigen test at treatment completion provides an objective measure of fungal clearance that is more reliable than clinical signs alone for determining when it is safe to discontinue therapy
Senior Dogs (9 Years and Older)
- Senior dogs with histoplasmosis face the same diagnostic challenges as adults but with compounded issues from age-related conditions that mimic histoplasmosis signs: chronic enteropathy, protein-losing nephropathy, hepatic disease, and intestinal neoplasia (lymphoma, adenocarcinoma) all produce weight loss, hypoalbuminemia, and diarrhea in older dogs; histoplasmosis must be included in the initial differential workup even when neoplasia seems more likely, because the urine antigen test and rectal scraping cytology are inexpensive and fast relative to the cost of a full cancer staging evaluation, and missing a treatable fungal disease in favor of a cancer diagnosis is a preventable error
- Senior dogs on multiple concurrent medications require careful review before adding itraconazole; the drug is a potent CYP3A4 inhibitor and can significantly elevate plasma concentrations of co-administered drugs including cyclosporine (commonly used in senior dogs for immune-mediated diseases), certain cardiac medications (digoxin, some antiarrhythmics), and benzodiazepines; a drug interaction review by the veterinarian is essential before starting itraconazole in a senior dog on a complex medication regimen
- Adrenal gland histoplasmosis in senior dogs can be particularly challenging because older dogs already have a higher prevalence of concurrent adrenal pathology (adrenocortical adenoma, Cushing’s disease); bilateral adrenal enlargement on ultrasound should prompt evaluation for histoplasmosis (urine antigen, fine-needle aspirate of the adrenal if safe) before a presumptive diagnosis of pheochromocytoma or adrenal-dependent Cushing’s disease is pursued; hypoadrenocorticism secondary to histoplasmic adrenal destruction is treatable with antifungals plus temporary mineralocorticoid supplementation during the recovery period
Myths and Facts About Histoplasmosis in Dogs
My dog has IBD because the steroids made them worse and now we know it’s something fungal, but that’s rare so it probably isn’t histoplasmosis.
Worsening of chronic diarrhea and hypoalbuminemia on corticosteroids in a dog from an endemic state is a classic warning sign of histoplasmosis, not a rare coincidence. Histoplasmosis is the most common systemic fungal disease in dogs in the Mississippi and Ohio River valley states, where tens of thousands of dogs are affected annually. Corticosteroids suppress the macrophage activation that is the primary defense against intracellular Histoplasma yeast, allowing unchecked replication; deterioration on immunosuppression strongly suggests a fungal or other infectious etiology and should prompt immediate antigen testing and cytology before resuming immunosuppressive therapy.
Histoplasmosis is a lung disease, so my dog who only has diarrhea and weight loss couldn’t have it.
In humans, histoplasmosis typically presents as a respiratory illness (because humans clear pulmonary infection more efficiently than dogs). In dogs, the disease predominantly disseminates from the lungs to the gastrointestinal tract via macrophage trafficking, so the dominant clinical presentation is GI disease: chronic diarrhea, severe weight loss, protein-losing enteropathy, and hepatosplenomegaly. Many dogs with histoplasmosis have minimal or no cough and no obvious respiratory signs. The GI-dominant presentation is a defining characteristic of canine histoplasmosis that distinguishes it from the human form of the disease.
My dog finished the itraconazole and the diarrhea is gone, so treatment is complete and no monitoring is needed.
Clinical resolution of signs (resolution of diarrhea, weight regain, normalization of albumin) occurs well before complete fungal clearance in many dogs with histoplasmosis. Stopping itraconazole at clinical resolution rather than at antigen negativity is one of the most common causes of histoplasmosis relapse. Treatment should continue for at least 30 days after urine antigen testing becomes negative (not just until signs resolve), and serial urine antigen monitoring at 30-day intervals for 6 months after stopping treatment should continue to detect early relapse before it becomes severe.
Red Flags: Signs Requiring Same-Day or Emergency Evaluation
- Serum albumin below 1.5 g/dL with visible ascites, limb edema, or labored breathing from pleural effusion: severe hypoalbuminemia from histoplasmosis protein-losing enteropathy can cause third-space fluid accumulation that compromises circulation and breathing; this degree of hypoalbuminemia represents advanced disease and warrants emergency hospitalization with concurrent albumin support and initiation of antifungal therapy; do not wait for culture results before starting itraconazole
- Pancytopenia (low red blood cells, white blood cells, and platelets simultaneously) with fever and chronic diarrhea in a dog from an endemic area: pancytopenia from bone marrow histoplasmosis is a medical emergency that indicates widespread reticuloendothelial system involvement; these dogs are at high risk for secondary bacterial infection from leukopenia and spontaneous hemorrhage from thrombocytopenia; emergency evaluation including bone marrow aspirate cytology and urine antigen testing should be performed immediately
- Acute collapse, hypotension, or electrolyte abnormalities (low sodium, high potassium) in a dog being treated for or suspected to have histoplasmosis: adrenal histoplasmosis can cause acute adrenal insufficiency (Addisonian crisis); this is a life-threatening emergency requiring immediate IV fluid resuscitation, dexamethasone (which does not interfere with ACTH stimulation testing), and evaluation for concurrent histoplasmic adrenal destruction
- New neurological signs (seizures, ataxia, altered mentation, sudden blindness) in a dog with confirmed or suspected histoplasmosis: CNS dissemination of histoplasmosis carries the worst prognosis and requires immediate neurological evaluation; itraconazole penetrates the CNS poorly, and CNS histoplasmosis requires either fluconazole (better CNS penetration) or amphotericin B induction therapy; any dog being treated with itraconazole for systemic histoplasmosis who develops new neurological signs should be evaluated for CNS dissemination and potential need to change antifungal therapy
- Severe respiratory distress in a dog with active histoplasmosis: while less common than in blastomycosis, diffuse pulmonary histoplasmosis can cause respiratory failure; acute respiratory decompensation in a dog with known or suspected histoplasmosis requires emergency oxygen support and immediate antifungal therapy; some of these dogs require amphotericin B rather than oral itraconazole for rapid fungicidal activity while respiratory support is provided
Frequently Asked Questions About Histoplasmosis in Dogs
What is histoplasmosis in dogs?
Histoplasmosis is a systemic fungal infection caused by Histoplasma capsulatum, a thermally dimorphic fungus found in soil enriched with bird droppings (starlings, blackbirds, chickens) and bat guano in the Mississippi and Ohio River valley states and beyond. Unlike blastomycosis, which primarily causes lung disease, histoplasmosis in dogs disseminates from the lungs to the GI tract via infected macrophages, causing chronic diarrhea, weight loss, protein-losing enteropathy, and hepatosplenomegaly as the dominant clinical syndrome.
How is histoplasmosis different from blastomycosis in dogs?
Both are dimorphic fungal diseases endemic to the Mississippi/Ohio River valley, but they differ significantly in clinical presentation: blastomycosis primarily causes pulmonary disease with miliary lung nodules often mistaken for cancer, while histoplasmosis in dogs predominantly causes GI disease with chronic diarrhea, severe weight loss, and hypoalbuminemia. Histoplasma yeast are small (2 to 4 micrometers) and obligately intracellular in macrophages; Blastomyces yeast are large (8 to 15 micrometers), extracellular, and show characteristic broad-based budding. Treatment duration is also longer for histoplasmosis (4 to 6 months versus 2 to 3 months for blastomycosis).
How is histoplasmosis diagnosed in dogs?
The fastest diagnostic method is rectal mucosal scraping cytology: a simple scraping of the rectal lining reveals macrophages packed with small intracellular yeast organisms under the microscope, requires no anesthesia, and can provide a same-day diagnosis. The urine Histoplasma antigen EIA (MiraVista Diagnostics) has approximately 85 to 90 percent sensitivity and is the best non-invasive confirmatory test. Fine-needle aspiration of enlarged lymph nodes, liver, or spleen also frequently yields the diagnosis.
What is the treatment for histoplasmosis in dogs?
Itraconazole 5 mg/kg orally once daily with a fatty meal is the treatment of choice, for a minimum of 4 to 6 months. Treatment continues until at least 30 days after urine antigen testing turns negative, not just until clinical signs resolve. Monthly liver enzyme monitoring is required. Severely hypoalbuminemic dogs need concurrent nutritional support and sometimes plasma or albumin infusions. Corticosteroids must be strictly avoided during treatment for histoplasmosis, as they allow unchecked fungal replication within macrophages.
Where is histoplasmosis most common in dogs?
The highest-risk areas are the Mississippi and Ohio River valley states: Missouri, Arkansas, Tennessee, Kentucky, Indiana, Illinois, Iowa, Ohio, and Mississippi. The mid-Atlantic and Appalachian regions (Pennsylvania, Maryland, Virginia, West Virginia) also have significant prevalence due to bat cave populations and old agricultural buildings. Within endemic areas, dogs near old chicken coops, active bird roost sites (starlings, blackbirds), and bat-inhabited caves or mines face the highest environmental exposure risk.
Can my dog give me histoplasmosis?
No. Direct dog-to-human transmission of histoplasmosis is not documented. Both dogs and humans acquire histoplasmosis from the same environmental source: fungal spores in contaminated soil. Normal handling and hygiene when caring for an infected dog is sufficient protection. However, if you share outdoor environments with your dog in an endemic area near a bird roost or old chicken operation, you face the same environmental exposure your dog encountered.
Why did my dog get worse on steroids for IBD?
Worsening on corticosteroids in a dog with apparent IBD from an endemic area is a classic red flag for histoplasmosis. Histoplasma capsulatum survives and replicates inside macrophages; corticosteroids suppress macrophage activation, which is the primary defense against intracellular fungi. Immunosuppression allows unchecked fungal replication within macrophages and accelerates GI dissemination. Any dog from an endemic state whose diarrhea and protein loss worsen on steroids should have urine antigen testing and rectal scraping cytology immediately before further immunosuppressive therapy is considered.
For more guides on keeping your dog healthy, browse all our Dog Health articles.
Explore Dog Health Articles